BTG On Other Exchanges
text size: T | T
Back to Snapshot
Company Description

Contact Info

5 Fleet Place

London, EC4M 7RD

United Kingdom

Phone: 44 20 7575 0000

Fax: 44 20 7575 0010

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals, and Licensing segments. The Interventional Medicine segment offers interventional oncology products, such as bead products and TheraSphere for treatment of liver cancer; interventional vascular products consisting of EkoSonic for treatment of blood clots and Varithena for the treatment of varicoseveins; and interventional pulmonology products, including PneumRx Coil for advanced emphysema, a debilitating lung disease. The Specialty Pharmaceuticals segment provides antidote products, such as CroFab for the treatment of envenomations from the copperhead snake; DigiFab for the treatment of digoxin toxicity; Voraxaze for high-dose methotrexate toxicity; and Vistogar for the treatment of side effects of overexposure to the chemotherapeutic 5-fluorouracil. The Licensing segment offers Zytiga for treatment of prostate cancer; Two-Part Hip Cup for hip joint replacement; and Lemtrada for treatment of multiple sclerosis. BTG plc is developing a biodegradable bead product for use in non-malignant tumours, such as uterine fibroids; and manufactures and commercializes therapeutic ultrasound devices. The company was founded in 1948 and is headquartered in London, the United Kingdom.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

BTG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BTG.
View Industry Companies

Industry Analysis


Industry Average

Valuation BTG Industry Range
Price/Earnings 37.8x
Price/Sales 5.0x
Price/Book 2.7x
Price/Cash Flow 23.8x
TEV/Sales 5.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BTG PLC, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at